Tumor-derived secretory clusterin induces epithelial-mesenchymal transition and facilitates hepatocellular carcinoma metastasis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Journal of Biochemistry and Cell Biology

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.biocel.2012.09.012PMID 23010347
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer.

  2012influential reference
• Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma

  2012cited by this paper
• Clusterin Is a Critical Downstream Mediator of Stress-Induced YB-1 Transactivation in Prostate Cancer

  2011cited by this paper
• Metadherin Promotes Hepatocellular Carcinoma Metastasis through Induction of Epithelial–Mesenchymal Transition

  2011cited by this paper
• Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.

  2011cited by this paper
• Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer

  2011influential reference
• Impact of Protein Stability, Cellular Localization, and Abundance on Proteomic Detection of Tumor-Derived Proteins in Plasma

  2011cited by this paper
• ITIH3 is a potential biomarker for early detection of gastric cancer.

  2010influential reference
• Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies

  2010cited by this paper
• Effects of clusterin over-expression on metastatic progression and therapy in breast cancer

  2010influential reference
• LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.

  2010cited by this paper
• Stanniocalcin 1 and ovarian tumorigenesis.

  2010cited by this paper
• Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to α fetoprotein.

  2010cited by this paper
• Proteomic approaches to cancer biomarkers.

  2010cited by this paper
• Reduced plasma APOA1 level is associated with gastric tumor growth in MKN45 mouse xenograft model.

  2010influential reference
• Up-regulation of Krüppel-like factor 8 promotes tumor invasion and indicates poor prognosis for hepatocellular carcinoma.

  2010cited by this paper
• Targeting the Cytoprotective Chaperone, Clusterin, for Treatment of Advanced Cancer

  2010cited by this paper
• Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway.

  2009cited by this paper
• Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery

  2009cited by this paper
• Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients

  2009cited by this paper
• Afamin and Apolipoprotein A-IV: Novel Protein Markers for Ovarian Cancer

  2009cited by this paper
• Quantitative proteomics and biomarker discovery in human cancer

  2009cited by this paper
• Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer

  2009cited by this paper
• A mouse model repository for cancer biomarker discovery.

  2008cited by this paper
• Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy‐dye labeling combined with three‐dimensional fractionation

  2008cited by this paper
• A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.

  2008cited by this paper
• Statistically integrated metabonomic-proteomic studies on a human prostate cancer xenograft model in mice.

  2006cited by this paper
• Clusterin plays an important role in hepatocellular carcinoma metastasis

  2006cited by this paper
• Mass Spectrometric Identification of Human Prostate Cancer-derived Proteins in Serum of Xenograft-bearing Mice*

  2006cited by this paper
• Oncogenic role of clusterin overexpression in multistage colorectal tumorigenesis and progression.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis

  2005cited by this paper
• Overexpression of clusterin in human hepatocellular carcinoma.

  2004cited by this paper
• Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma.

  2000cited by this paper

• Pseudoexfoliation syndrome: A review of pathogenesis

  2024cites this paper
• Oncomatrix: Molecular Composition and Biomechanical Properties of the Extracellular Matrix in Human Tumors

  2024cites this paper
• Decoding CLU (Clusterin): Conquering cancer treatment resistance and immunological barriers.

  2024cites this paper
• The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing

  2023cites this paper
• Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies

  2023cites this paper
• HSF1 is involved in immunotherapeutic response through regulating APOJ/STAT3-mediated PD-L1 expression in hepatocellular carcinoma

  2022cites this paper
• The role and function of CLU in cancer biology and therapy

  2022influential citation
• Inhibition of Clusterin Represses Proliferation by Inducing Cellular Senescence in Pancreatic Cancer

  2022cites this paper
• The multiple roles and therapeutic potential of clusterin in non-small-cell lung cancer: a narrative review

  2021cites this paper
• Comprehensive Identification of Potential Crucial Genes and miRNA-mRNA Regulatory Networks in Papillary Thyroid Cancer

  2021cites this paper
• Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

  2021cites this paper
• Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma

  2021cites this paper
• Inactivation of tumor suppressor gene Clusterin leads to hyperactivation of TAK1-NF-κB signaling axis in lung cancer cells and denotes a therapeutic opportunity

  2020cites this paper
• Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy.

  2020cites this paper
• Clusterin: Always protecting. Synthesis, function and potential issues.

  2020cites this paper
• Secretory Clusterin AS A Novel Molecular-targeted for Inhibiting Hepatocellular Carcinoma Growth.

  2020cites this paper
• Emerging role of tumor cell plasticity in modifying therapeutic response

  2020cites this paper
• Apolipoproteins and cancer

  2019cites this paper
• CMAR_A_196273 2405..2414

  2019cites this paper
• Clusterin increases mitochondrial respiratory chain complex I activity and protects against hexavalent chromium-induced cytotoxicity in L-02 hepatocytes.

  2019cites this paper
• The role of Clusterin in cancer metastasis

  2019cites this paper
• Extracellular Hsp90α and clusterin synergistically promote breast cancer epithelial-to-mesenchymal transition and metastasis via LRP1

  2019cites this paper
• The Role of Breast Cancer Stem Cells as a Prognostic Marker and a Target to Improve the Efficacy of Breast Cancer Therapy

  2019cites this paper
• Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity

  2019cites this paper
• Heat Shock Proteins in Digestive Tract Cancer: Molecular Mechanism and Therapeutic Potential

  2019cites this paper
• Role of secretory clusterin in hepatocarcinogenesis.

  2018cites this paper
• Clusterin enhances AKT2‐mediated motility of normal and cancer prostate cells through a PTEN and PHLPP1 circuit

  2018cites this paper
• Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

  2018cites this paper
• Estimation of Clusterin Role as a Biomarker for Virus C-related Hepatocellular Carcinoma

  2018cites this paper
• Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis

  2017cites this paper
• Immediate early response protein 2 regulates hepatocellular carcinoma cell adhesion and motility via integrin β1-mediated signaling pathway.

  2017cites this paper
• O-linked N-acetylglucosamine transferase enhances secretory clusterin expression via liver X receptors and sterol response element binding protein regulation in cervical cancer

  2017cites this paper
• Targeting epithelial-mesenchymal plasticity in cancer: clinical and preclinical advances in therapy and monitoring.

  2017cites this paper
• Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target.

  2017cites this paper
• Clusterin inhibition mediates sensitivity to chemotherapy and radiotherapy in human cancer

  2017cites this paper
• EMT: Present and future in clinical oncology

  2017cites this paper
• Pathogenic Features of Liver Metastasis: Mechanisms Involving Platelets, Tumor Stroma, Epithelial-Mesenchymal Transition, and the Premetastatic Niche

  2017cites this paper
• Mechanisms of Invasion and Metastasis: Role of the Stromal Liver Cancer Microenvironment, Epithelial-Mesenchymal Transition, and the Tumor Vascular Bed

  2017cites this paper
• Oncogenic Secretory Clusterin: A Promising Therapeutic Target for Hepatocellular Carcinoma

  2017influential citation
• Clusterin as a therapeutic target

  2017cites this paper
• Clusterin and neuropilin-2 as potential biomarkers of tumor progression in benzo[a]pyrene-transformed 16HBE cells xenografted nude mouse model.

  2017cites this paper
• Clusterin modulates transdifferentiation of non-small-cell lung cancer

  2017cites this paper
• The Role of Clusterin in Carcinogenesis and its Potential Utility as Therapeutic Target.

  2016cites this paper
• EMT, cell plasticity and metastasis

  2016cites this paper
• Mechanisms of Invasion and Metastasis: Role of the Liver Cancer Microenvironment

  2016cites this paper
• Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal

  2016cites this paper
• Combined expression of E-cadherin and KAI 1 is associated withlymph node metastasis and poor prognosis in breast cancer

  2016cites this paper
• A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma

  2016cites this paper
• Prognostic Role of Secretory Clusterin in Multiple Human Malignant Neoplasms: A Meta-Analysis of 26 Immunohistochemistry Studies

  2016cites this paper
• Indole-3- carbinol enhances sorafenib cytotoxicity in hepatocellular carcinoma cells: A mechanistic study

  2016cites this paper
• Aberrant expression of Golgi protein 73 is indicative of a poor outcome in hepatocellular carcinoma.

  2016cites this paper
• Gas6/Axl Axis Contributes to Chemoresistance and Metastasis in Breast Cancer through Akt/GSK-3β/β-catenin Signaling

  2016cites this paper
• Oncogenic secretory clusterin in hepatocellular carcinoma: Expression at early staging and emerging molecular target

  2016cites this paper
• Heat shock proteins in hepatocellular carcinoma: Molecular mechanism and therapeutic potential

  2016cites this paper
• Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2/ADM cells

  2015cites this paper
• Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.

  2015cites this paper
• Identification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs

  2015influential citation
• Clusterin: Review of research progress and looking ahead to direction in hepatocellular carcinoma.

  2015cites this paper
• Diagnostic and prognostic significance of secretory clusterin expression in patients with hepatocellular carcinoma

  2015cites this paper
• Clusterin gene is predominantly regulated by histone modifications in human colon cancer and ectopic expression of the nuclear isoform induces cell death.

  2015cites this paper
• Transcriptome and proteome of human hepatocellular carcinoma reveal shared metastatic pathways with significant genes

  2015cites this paper
• Dynamic Expression Patterns of Differential Proteins during Early Invasion of Hepatocellular Carcinoma

  2014cites this paper
• Clusterin stimulates the chemotactic migration of macrophages through a pertussis toxin sensitive G-protein-coupled receptor and Gβγ-dependent pathways.

  2014cites this paper
• Overexpression of fibrinogen-like protein 2 induces epithelial-to-mesenchymal transition and promotes tumor progression in colorectal carcinoma

  2014cites this paper
• Epithelial-mesenchymal transition: molecular pathways of hepatitis viruses-induced hepatocellular carcinoma progression

  2014cites this paper
• Clusterin facilitates metastasis by EIF3I/Akt/MMP13 signaling in hepatocellular carcinoma

  2014cites this paper
• Serum differential protein identification of Xinjiang Kazakh esophageal cancer patients based on the two-dimensional liquid-phase chromatography and LTQ MS

  2014cites this paper
• PACAP inhibits tumor growth and interferes with clusterin in cervical carcinomas

  2014cites this paper
• Bone metastases in hepatocellular carcinoma: an emerging issue

  2013cites this paper
• Epithelial splicing regulator protein 1 and alternative splicing in somatotroph adenomas.

  2013cites this paper
• NANOG promotes liver cancer cell invasion by inducing epithelial-mesenchymal transition through NODAL/SMAD3 signaling pathway.

  2013cites this paper
• Comparative multidimensional molecular analyses of pediatric diffuse intrinsic pontine glioma reveals distinct molecular subtypes

  2013cites this paper
• The Molecular Chaperone Apolipoprotein J/Clusterin as a Sensor of Oxidative Stress: Implications in Therapeutic Approaches - A Mini-Review

  2013cites this paper
• Clusterin Protects Hepatocellular Carcinoma Cells from Endoplasmic Reticulum Stress Induced Apoptosis through GRP78

  2013cites this paper
• Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression

  2013cites this paper